These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24305610)

  • 41. Risk of Melanoma With Phosphodiesterase Type 5 Inhibitor Use Among Patients With Erectile Dysfunction, Pulmonary Hypertension, and Lower Urinary Tract Symptoms.
    Shkolyar E; Li S; Tang J; Eisenberg ML
    J Sex Med; 2018 Jul; 15(7):982-989. PubMed ID: 29884444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Impact of the pharmacokinetic properties of PDE5 inhibitors on the dose/sexual intercourse interval].
    Giuliano F; Vicaut E; Jeanpetit Y
    Prog Urol; 2008 Sep; 18(8):536-42. PubMed ID: 18760744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erectile dysfunction (ED) is a shared sexual concern of couples II: association of female partner characteristics with male partner ED treatment seeking and phosphodiesterase type 5 inhibitor utilization.
    Fisher WA; Eardley I; McCabe M; Sand M
    J Sex Med; 2009 Nov; 6(11):3111-24. PubMed ID: 19674250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Duration of erection: does it really matter? A randomized, double-blind clinical trial to assess the impact of vardenafil ODT on duration of erection and its correlation with patients' and partners' sexual quality of life and duration of intercourse: the VADEOPEN study.
    Martin-Morales A; Gutiérrez-Hernández P; Romero-Otero J; Romero-Martín JA;
    J Sex Med; 2014 Jun; 11(6):1527-38. PubMed ID: 24628736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphodiesterase-5 inhibitors could be efficacious in the treatment of erectile dysfunction after radiotherapy for prostate cancer: a systematic review and meta-analysis.
    Yang L; Qian S; Liu L; Pu C; Yuan H; Han P; Wei Q
    Urol Int; 2013; 90(3):339-47. PubMed ID: 23221333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cognitive changes predict continued recovery of erectile functioning versus relapse after discontinuation of sildenafil treatment for male erectile dysfunction.
    van Lankveld JJ; van den Hout MA; Spigt MG; van Koeveringe GA
    Psychosom Med; 2003; 65(4):709-18. PubMed ID: 12883126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Application of the vacuum erectile device in penile rehabilitation for erectile dysfunction after radical prostatectomy].
    Lin H; Wang G; Wang R
    Zhonghua Nan Ke Xue; 2015 Mar; 21(3):195-9. PubMed ID: 25898548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The safety and efficacy of Avanafil, a new 2(nd) generation PDE5i: comprehensive review and meta-analysis.
    Corona G; Rastrelli G; Burri A; Jannini EA; Maggi M
    Expert Opin Drug Saf; 2016; 15(2):237-47. PubMed ID: 26646748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
    Buvat J; Büttner H; Hatzimouratidis K; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Advances in the studies of refractory erectile dysfunction].
    Wang BY; Jiang R
    Zhonghua Nan Ke Xue; 2013 Jan; 19(1):82-5. PubMed ID: 23469669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The EPIFARM study: an observational study in 574 community pharmacies in Spain characterizing patient profiles of men asking for erectile dysfunction medication.
    Morales AM; Ibáñez J; Machuca M; Pol-Yanguas E; Schnetzler G; Renedo VP
    J Sex Med; 2010 Sep; 7(9):3153-60. PubMed ID: 20584119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in sexual inhibition and excitation during PDE5I therapy.
    Louizos CC; McCann B; Knight PK
    Int J Impot Res; 2014; 26(4):146-50. PubMed ID: 24451167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: a randomized, double-blind, placebo-controlled study.
    Martín-Morales A; Graziottin A; Jaoudé GB; Debruyne F; Buvat J; Beneke M; Neuser D
    J Sex Med; 2011 Oct; 8(10):2831-40. PubMed ID: 21679304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil.
    Kim E; Seftel A; Goldfischer E; Baygani S; Burns P
    Curr Med Res Opin; 2015 Feb; 31(2):379-89. PubMed ID: 25455432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response to treatment with tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
    Shabsigh R; Kim ED; Rosen RC; Shinghal R; Natanegara F; Muram D; Wong DG
    Int J Impot Res; 2008; 20(6):554-60. PubMed ID: 18997808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
    Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
    Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function.
    Son H; Park K; Kim SW; Paick JS
    Asian J Androl; 2004 Jun; 6(2):117-20. PubMed ID: 15154085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erectile Dysfunction Medications and Skin Cancer: An Analysis in US Veterans.
    Christie A; Vera PL; Higgins M; Kumar S; Lane M; Preston D
    Urology; 2019 Apr; 126():116-120. PubMed ID: 30735744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing satisfaction in men and their female partners after treatment with phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Huang ST; Jiann BP
    Int J Impot Res; 2013 Sep; 25(5):178-82. PubMed ID: 23466660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An investigation of sexual dysfunction in female partners of men with erectile dysfunction: how interviews expand on questionnaire responses.
    Conaglen HM; O'Connor EJ; McCabe MP; Conaglen JV
    Int J Impot Res; 2010; 22(6):355-62. PubMed ID: 20962793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.